Keyphrases
Recurrent Pulmonary Embolism
100%
Statin Therapy
100%
Statins
100%
Vitamin K Antagonists
66%
Antagonist Treatment
50%
Cardiovascular Events
33%
Pulmonary Embolism
33%
Anticoagulant Treatment
33%
All-cause Mortality
16%
Cardiovascular Mortality
16%
Dose-response Relationship
16%
Cox Regression Analysis
16%
Hospital Discharge
16%
Risk Reduction
16%
Pharmacy Records
16%
Linkage System
16%
First Episode
16%
Long-term Treatment
16%
Median Range
16%
Recurrence Risk
16%
Hospital Discharge Records
16%
Acute Pulmonary Embolism
16%
Recurrent Venous Thromboembolism
16%
Population-based Registry
16%
Statin Use
16%
Large Reduction
16%
AIMS™
16%
Mean Standard Deviation
16%
Record Linkage
16%
Venous Thromboembolism
16%
Dutch Population
16%
Time of Use
16%
Acute Episodes
16%
Attractive Alternatives
16%
Adjusted Hazard Ratio
16%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Lung Embolism
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
85%
Antivitamin K
57%
Anticoagulant Agent
28%
Venous Thromboembolism
28%
Recurrent Disease
28%
Dose-Response Relationship
14%
All Cause Mortality
14%
Recurrence Risk
14%